BofA/Merrill Lynch Starts Lexicon Pharma (LXRX) at Underperform
Tweet Send to a Friend
BofA/Merrill Lynch initiated coverage on Lexicon Pharmaceuticals (NASDAQ: LXRX) with an Underperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE